Zydus gets USFDA nod for phase II trials of liver drug Industry-The Economic Times — February 23, 2017 comments off This development underlines the group’s commitment to bridging unmet healthcare needs with innovative therapies.
This development underlines the group’s commitment to bridging unmet healthcare needs with innovative therapies.